Ozempic, Xtandi Among Next 15 Drugs Selected for U.S. Price Talks

The Biden administration has announced the next 15 drugs to be included in Medicare's price negotiation program, a move that could significantly impact the pharmaceutical industry and drug prices for seniors. Among the selected drugs are popular weight loss medications like Ozempic and Wegovy, as well as blockbuster cancer medications and other drugs that account for a third of prescription drug spending in Medicare Part D. The negotiations are set to take effect in 2027, with drugmakers having until February 28 to decide whether to participate or face a hefty tax if they want to stay covered by Medicare and Medicaid.